Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation. [electronic resource]
Producer: 20010125Description: 383-8 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Blood Component Removal -- methods
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Etoposide -- administration & dosage
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation -- methods
- Hodgkin Disease -- drug therapy
- Humans
- Melphalan -- administration & dosage
- Middle Aged
- Multivariate Analysis
- Proportional Hazards Models
- Risk Factors
- Survival Rate
- Transplantation, Autologous -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.